Speciality Medicines IPO vs Wildnet Technologies IPO

Comparison between Speciality Medicines IPO and Wildnet Technologies IPO.

IPO Details

Speciality Medicines IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Wildnet Technologies IPO is a SME Bookbuilding proposed to list at BSE SME.

Issue Size and Price

The total issue size of Speciality Medicines IPO is up to ₹27.28 Cr whereas the issue size of the Wildnet Technologies IPO is up to ₹0.00 Cr. The final issue price of Speciality Medicines IPO is ₹124.00 per share and of Wildnet Technologies IPO is .

 Speciality Medicines IPOWildnet Technologies IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹117.00 per share
Issue Price (Upper)₹124.00 per share
Issue Price (Final)₹124.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size1000 shares
Fresh Issue Size22,00,000 shares3,50,000 shares
Fresh Issue Size (Amount)up to ₹27.28 Crup to ₹0.00 Cr
OFS Issue Size0 shares28,00,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total22,00,000 shares31,50,000 shares
Issue Size Total (Amount)up to ₹27.28 Crup to ₹0.00 Cr

IPO Timetable

Speciality Medicines IPO opens on Mar 20, 2026, while Wildnet Technologies IPO opens on . The closing date of Speciality Medicines IPO and Wildnet Technologies IPO is Mar 24, 2026, and , respectively.

Financials & KPIs

Speciality Medicines IPO P/E ratio is 9.27, as compared to Wildnet Technologies IPO P/E ratio of .

 Speciality Medicines IPOWildnet Technologies IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Oct 202531 Mar 202531 Mar 2024
Assets45.5739.9822.68
Total Income36.9358.5427.66
Profit After Tax6.068.612.93
EBITDA6.519.095.26
NET Worth36.4730.4215.06
Reserves and Surplus30.0423.989.95
Total Borrowing4.815.052.86
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets18.3315.7411.94
Total Income25.0122.4511.92
Profit After Tax3.471.630.97
NET Worth14.0810.619.01
Reserves and Surplus2.8410.608.99
Total Borrowing0.480.100.21
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)59.2899.99
Promoter Shareholding (Post-Issue)43.44
P/E Ratio9.27
Market Cap₹108.94 Cr.
ROE37.8528.07
ROCE33.39
Debt/Equity0.170.03
EPS₹13.38
RoNW28.3024.62

Shares Offered

In the Speciality Medicines IPO Retail Individual Investors (RII) are offered 10,90,000 shares while in Wildnet Technologies IPO retail investors are offered 10,90,000 shares. Qualified Institutional Buyers (QIB) are offered 21,000 shares in Speciality Medicines IPO and in Wildnet Technologies IPO.

 Speciality Medicines IPOWildnet Technologies IPO
Anchor Investor Reservation0 shares
Market Maker Reservation1,50,000 shares
QIB21,000 shares
NII10,89,000 shares
RII10,90,000 shares
Employee0 shares
Others
Total22,00,000 shares

Bids Received (Subscription)

Speciality Medicines IPO subscribed 2.27x in total, whereas Wildnet Technologies IPO subscribed .

Compare with others

Compare:

Speciality Medicines IPO Vs Wildnet Technologies IPO